Dutch clinical-stage biotechnology company Mucosis has appointed Thomas Johnston to the position of chief executive officer, effective immediately. Johnston joined Mucosis as chief business officer in May 2011, and succeeds Govert Schouten who is leaving the company to found an Internet start-up.
Rotunda Capital Partners adds former manufacturing CEO Keith Medick as operating partner
23 October 2026 · 1 min read
IFM Investors names Michael Kulper head of North America infrastructure
21 October 2026 · 1 min read
Siris launches services-focused October Capital under co-founder Frank Baker
21 October 2026 · 2 mins read
Weatherford Capital hires LLR Partners veteran Michael Pantilione for flagship strategy
20 October 2026 · 1 min read
GenNx360 Capital Partners names Nicole Vipperman as chief compliance officer
20 October 2026 · 1 min read
THL Partners hires HIG Capital’s Bruce Robertson as healthcare managing director
19 October 2026 · 2 mins read
Hamilton Lane names Hartley Rogers co-CEO as Erik Hirsch becomes executive co-chairman
16 October 2026 · 2 mins read
